This company was transferred to the archive: financial data is no longer updated!
Celgene Corp. (CELG)
Operating Profit Margin
since 2005
Beginner level
Calculation
Celgene Corp., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Operating income (loss)1 | ÷ | Net product sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | 34.01% | = | 100 | × | 5,191 | ÷ | 15,265 |
| Dec 31, 2017 | 36.28% | = | 100 | × | 4,707 | ÷ | 12,973 |
| Dec 31, 2016 | 28.31% | = | 100 | × | 3,167 | ÷ | 11,185 |
| Dec 31, 2015 | 24.61% | = | 100 | × | 2,255 | ÷ | 9,161 |
| Dec 31, 2014 | 33.30% | = | 100 | × | 2,519 | ÷ | 7,564 |
| Dec 31, 2013 | 28.43% | = | 100 | × | 1,809 | ÷ | 6,362 |
| Dec 31, 2012 | 32.43% | = | 100 | × | 1,746 | ÷ | 5,386 |
| Dec 31, 2011 | 30.70% | = | 100 | × | 1,443 | ÷ | 4,700 |
| Dec 31, 2010 | 28.21% | = | 100 | × | 990 | ÷ | 3,508 |
| Dec 31, 2009 | 32.78% | = | 100 | × | 842 | ÷ | 2,567 |
| Dec 31, 2008 | -68.50% | = | 100 | × | (1,464) | ÷ | 2,138 |
| Dec 31, 2007 | 32.69% | = | 100 | × | 425 | ÷ | 1,300 |
| Dec 31, 2006 | 21.52% | = | 100 | × | 175 | ÷ | 812 |
| Dec 31, 2005 | 18.76% | = | 100 | × | 84 | ÷ | 446 |
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-22), 10-K (filing date: 2011-03-01), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-17), 10-K (filing date: 2008-02-20), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-15).
1 US$ in millions
Comparison to Competitors
Celgene Corp., operating profit margin, long-term trends, comparison to competitors
| Celgene Corp. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | 34.01% | 11.94% | 19.49% | -39.57% | 45.55% | 43.77% | 37.83% | 37.77% | 20.84% |
| Dec 31, 2017 | 36.28% | 6.30% | 33.99% | -37.15% | 45.76% | 43.54% | 55.04% | 35.41% | 4.95% |
| Dec 31, 2016 | 28.31% | 15.27% | 36.60% | -12.53% | 44.74% | 44.99% | 58.87% | 27.38% | 0.58% |
| Dec 31, 2015 | 24.61% | 14.05% | 32.97% | -20.00% | 40.44% | 45.44% | 69.03% | 30.51% | -45.23% |
| Dec 31, 2014 | 33.30% | 12.84% | 17.09% | -9.71% | 32.03% | 40.94% | 62.37% | 29.74% | -119.30% |
| Dec 31, 2013 | 28.43% | 12.03% | 30.14% | -4.88% | 32.25% | 36.29% | 41.87% | 36.11% | -74.54% |
| Dec 31, 2012 | 32.43% | 20.28% | 31.65% | 5.42% | 33.52% | 33.64% | 42.67% | 33.20% | 0.15% |
| Dec 31, 2011 | 30.70% | 14.81% | — | 11.70% | 28.19% | 34.16% | 46.77% | -46.02% | 8.07% |
| Dec 31, 2010 | 28.21% | 17.31% | — | 8.56% | 37.82% | 26.48% | 53.62% | -21.23% | -485.51% |
| Dec 31, 2009 | 32.78% | 20.27% | — | 13.75% | 38.37% | 29.59% | 54.55% | -19.54% | -602.63% |
| Dec 31, 2008 | -68.50% | 19.28% | — | 14.12% | 35.50% | 29.62% | 52.68% | -37.67% | -263.65% |
| Dec 31, 2007 | 32.69% | 17.67% | — | 10.24% | 27.81% | 24.59% | 57.98% | -91.55% | -210.94% |
| Dec 31, 2006 | 21.52% | 9.09% | — | -21.33% | 27.71% | 16.40% | -29.32% | -169.68% | -105.86% |
| Dec 31, 2005 | 18.76% | 19.53% | — | 13.27% | 40.33% | 9.74% | 61.41% | -187.97% | -93.15% |
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-22), 10-K (filing date: 2011-03-01), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-17), 10-K (filing date: 2008-02-20), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-15).